Literature DB >> 11204085

Late occurrence of heart block after radiofrequency catheter ablation of the septal region: clinical follow-up and outcome.

G Pelargonio1, R I Fogel, T K Knilans, E N Prystowsky.   

Abstract

INTRODUCTION: There are few data regarding the occurrence of delayed heart block at least 24 hours after radiofrequency catheter ablation (RFCA) of AV nodal reentry or posteroseptal accessory pathways (APs). We investigated the late occurrence of heart block in this population, the clinical outcome, and whether findings at electrophysiologic study could have predicted its development. METHODS AND
RESULTS: Two of 418 patients with AV nodal reentry undergoing RFCA using a posterior approach and 1 of 54 patients with RFCA of a posteroseptal AP developed late heart block. Anterograde and retrograde AV nodal conduction before and after RFCA were normal. Patients received 12, 15, and 32 RFCA lesions, respectively, using a mean maximum power of 44 W. The RFCA sites were the posterior septum for posteroseptal AP and the posterior and mid-septum for patients with AV nodal reentry, with no His electrogram ever recorded at the ablation site. During RFCA, junctional tachycardia occurred with 1:1 VA conduction in the patient with a posteroseptal AP, but occasional intermittent single retrograde blocked complexes were present in both patients with AV nodal reentry. No rapid junctional tachycardia or >1 consecutive retrograde blocked complex was ever observed during RFCA. Persistent high-degree AV block with junctional escape developed 2 days after RFCA in the posteroseptal AP patient. A permanent pacemaker was implanted, and normal conduction was noted 16 days after RFCA. Both patients with AV nodal reentry complained of fatigue, mainly on exertion, 3 to 4 days after RFCA, and ECG-documented exercise-induced variable AV block was obtained. Because heart block resolved in our initial patient, a prolonged monitoring period was allowed. Symptoms disappeared at 13 and 8 days, and a follow-up treadmill test showed normal PR interval and no heart block. No recurrence of heart block has been seen in any of these three patients.
CONCLUSION: Late unexpected heart block after RFCA of AV nodal reentry and posteroseptal AP is rare, often resolves uneventfully in 1 to 2 weeks, and no specific electrophysiologic findings predicted its occurrence. Prolonged clinical observation is preferable to immediate pacemaker implantation in such patients.

Entities:  

Mesh:

Year:  2001        PMID: 11204085     DOI: 10.1046/j.1540-8167.2001.00056.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Late cure of focal ventricular arrhythmias post-catheter ablation: electrophysiological characteristics and long-term outcome.

Authors:  Weizhu Ju; Kai Gu; Bing Yang; Fengxiang Zhang; Hongwu Chen; Gang Yang; Mingfang Li; Linsheng Shi; Jinbo Yu; Fangyi Xiao; Qiang Xu; Ming Chu; Wenzhi Shen; Kejiang Cao; Minglong Chen
Journal:  J Interv Card Electrophysiol       Date:  2018-02-19       Impact factor: 1.900

2.  Late onset of heart block after open heart surgery for congenital heart disease.

Authors:  Leonardo Liberman; Robert H Pass; Allan J Hordof; Henry M Spotnitz
Journal:  Pediatr Cardiol       Date:  2007-09-01       Impact factor: 1.655

Review 3.  Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management.

Authors:  Giovanni Peretto; Alessandro Durante; Luca Rosario Limite; Domenico Cianflone
Journal:  Cardiol Res Pract       Date:  2014-01-06       Impact factor: 1.866

4.  Late occurrence of transient advanced second degree atrioventricular block after successful transcatheter cryoablation of atrioventricular nodal reentry tachycardia.

Authors:  Maria Malaya C Dorotan-Guevara; Michael S Crapanzano; Christopher S Snyder
Journal:  Case Rep Cardiol       Date:  2012-10-14

Review 5.  Vagomimetic effects of fingolimod: physiology and clinical implications.

Authors:  Emilio Vanoli; Francesco Pentimalli; Gianluca Botto
Journal:  CNS Neurosci Ther       Date:  2014-06       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.